Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × ribociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Neoplasm Metastasis 3 Neoplasms 2 Melanoma 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Lung Neoplasms 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 ER+ HER2- Advanced Breast Cancer 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Diseases 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Fluorouracil 9 Oxaliplatin 8 Nivolumab 8 Leucovorin 7 Capecitabine 7 pembrolizumab 3 Trastuzumab 3 Specimen Handling 3 Paclitaxel 3 Cisplatin 3 zimberelimab 2 zanidatamab 2 dehydroftorafur 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Docetaxel 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 quemliclustat 1 obeticholic acid 1 durvalumab 1 Taxes 1 Ramucirumab 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡